Company Details
|
|
Address
|
Svardvagen 11, Danderyd, SE-182 33
|
|
Telephone
|
+46 8 622 2300
|
|
Fax
|
+46 8 622 2312
|
Executives
|
|
Executive Chairman
|
Lothar Koob (0.00% holding)
|
|
Chief Executive
|
Mikael Strindlund (0.00% holding)
|
|
Finance Director
|
(0.00% holding)
|
|
Non-Exec Director
|
Tim Haines (0.00% holding)
|
Main Shareholders
|
|
|
HealthCap: 12.6% Chase Nominees: 11.5% Bank of New York (Nominees): 10.9% Abingworth: 10.6%
|
Advisers
|
|
Nominated Adviser
|
Nomura
|
|
Nominated Broker
|
Nomura
|
|
Solicitors
|
Advokatfirman Lindahl
|
|
Auditors
|
Deloitte
|
|
Registrar
|
n/a
|
|
Commentary
|
|
Technology leader in tomosynthesis-based 3D medical imaging
|
Company Data |
| Code |
XCT |
| Sedol |
SE00009631 |
| Shares In Issue |
43.545 m |
| Indices
|
Aim |
| Entry on AIM |
01/02/2006 |
| Interim Results |
Aug |
| Final Results |
Mar |
| Year End |
Dec |
| Accounts Due |
Mar |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
|
| |
|
|